Patrick Schmid

ORCID: 0000-0003-1978-5082

Also affiliated with International School of Management

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy”.

Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy

Clinical Infectious Diseases(2023)10.1093/cid/ciad286

N/A

0.590DataRank · unranked

50 citations

Frédérique Chammartin, José Damas, Alexandra Calmy, David Haerry, M Stöckle +54 more

Antibody and T-Cell Response to Bivalent Booster SARS-CoV-2 Vaccines in People With Compromised Immune Function: COVERALL-3 Study

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae291

N/A

0.208DataRank · unranked

3 citations

Frédérique Chammartin, Annette Audigé, Anna Eichenberger, Dominique L. Braun, Patrizia Amico +84 more

Self-reported neurocognitive complaints in the Swiss HIV Cohort Study: a viral genome-wide association study

Brain Communications(2024)10.1093/braincomms/fcae188

N/A

0.208DataRank · unranked

3 citations

Chloé Pasin, Matthias Cavassini, Mélanie Bieler-Aeschlimann, Paul Frischknecht, Katharina Kusejko +60 more

Efficacy and Safety of Dolutegravir Plus Emtricitabine vs Combined Antiretroviral Therapy for the Maintenance of HIV Suppression: Results Through Week 144 of the SIMPL’HIV Trial

Open Forum Infectious Diseases(2024)10.1093/ofid/ofae618

N/A

0.104DataRank · unranked

1 citations

Delphine Sculier, Gilles Wandeler, Sabine Yerly, Marcel Stoeckle, Enos Bernasconi +16 more

Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV

Scientific Reports(2022)10.1038/s41598-021-04308-2

N/A

0DataRank · unranked

61 citations

Konstantin Popadin, Christian W. Thorball, Md Mesbah Uddin, Markella V. Zanni, Bing Yu +65 more

Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland

The Lancet Regional Health - Europe(2023)10.1016/j.lanepe.2023.100793

N/A

0DataRank · unranked

51 citations

Susana Alves Saldanha, Fabian Schaller, Eva Choong, Aline Munting, Matthias Cavassini +65 more

Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2)

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad150

N/A

0DataRank · unranked

9 citations

Frédérique Chammartin, Irène A. Abela, Patrizia Amico, Marcel Stoeckle, Anna Eichenberger +85 more

Revealing viral and cellular dynamics of HIV-1 at the single-cell level during early treatment periods

Cell Reports Methods(2023)10.1016/j.crmeth.2023.100485

N/A

0DataRank · unranked

4 citations

Yuepeng Zhang, Julian Spagnuolo, Alexander Thielen, Martin Däumer, Carsten Wiethe +58 more

Time Trends in Causes of Death in People With HIV: Insights From the Swiss HIV Cohort Study

Clinical Infectious Diseases(2024)10.1093/cid/ciae014

N/A

0DataRank · unranked

41 citations

Jessy J. Duran Ramirez, Maxime Hentzien, Matthias Cavassini, Enos Bernasconi, Eveline Hofmann +55 more

HIV-1 Low-Level Viremia Predicts Viral Failure in Participants on Antiretroviral Therapy in the Swiss HIV Cohort Study

Clinical Infectious Diseases(2024)10.1093/cid/ciae569

N/A

0DataRank · unranked

14 citations

J.H. Meier, Marcel Stoeckle, Hansjakob Furrer, Alexandra Calmy, Matthias Cavassini +55 more

Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long‐Acting Intramuscular Injection in Real‐World People with HIV

Clinical Pharmacology & Therapeutics(2024)10.1002/cpt.3240

N/A

0DataRank · unranked

12 citations

Susana Alves Saldanha, Fabian Schaller, Eva Choong, François Veuve, Aline Munting +20 more

Circulating HBV RNA and Hepatitis B Core–Related Antigen Trajectories in Persons With HIV/HBV Coinfection and Hepatitis B Surface Antigen Loss During Tenofovir Therapy

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae189

N/A

0DataRank · unranked

2 citations

Anders Boyd, Marie‐Laure Plissonnier, Barbara Testoni, Luisa Salazar‐Vizcaya, Franziska Suter‐Riniker +60 more

Predictors of Virological Failure and Time to Viral Suppression of First-Line Integrase Inhibitor–Based Antiretroviral Treatment

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1614

N/A

0DataRank · unranked

44 citations

Alexandra Scherrer, Roger D. Kouyos, Michael Huber, Hans H. Hirsch, Matthieu Perreau +49 more

Deciphering Factors Linked With Reduced Severe Acute Respiratory Syndrome Coronavirus 2 Susceptibility in the Swiss HIV Cohort Study

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae002

N/A

0DataRank · unranked

0 citations

Anthony Hauser, Magdalena Schwarzmüller, Chloé Pasin, Katharina Kusejko, Selina Epp +62 more

Genetic variation near CXCL12 is associated with susceptibility to HIV-related non-Hodgkin lymphoma

Haematologica(2020)10.3324/haematol.2020.247023

N/A

0DataRank · unranked

7 citations

Tiphaine Oudot‐Mellakh, Nava Ehsan, Christian Hammer, Federico Santoni, Jonathan Niay +19 more

Assessing the drivers of syphilis among men who have sex with men in Switzerland reveals a key impact of screening frequency: A modelling study

PLoS Computational Biology(2021)10.1371/journal.pcbi.1009529

N/A

0DataRank · unranked

9 citations

Luisa Salazar‐Vizcaya, Axel J. Schmidt, Viacheslav N. Kachalov, Katharina Kusejko, Maria Christine Thurnheer +11 more

Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group

Clinical Infectious Diseases(2021)10.1093/cid/ciab628

N/A

0DataRank · unranked

7 citations

Benjamin Hampel, David García Núñez, Manuel Battegay, Anna Hachfeld, Enos Bernasconi +56 more